21st Century Olympic Doping
By Robin Donovan,
NEO.LIFE
| 07. 22. 2021
Gene editing for performance enhancement may not be the Tokyo cheat, but we asked the experts how far off it might be.
Photo by Serena Repice Lentini on Unsplash
The 2020 Summer Olympics in Tokyo, finally set to kick off this week, have already been upended. After waiting an additional year to qualify, Games athletes will now compete in largely empty venues in an event sparked not by the running of a torch, but a series of closed-door ceremonies. Meanwhile, athletes hope to avoid joining a growing number of competitors who have tested positive for COVID-19 since arriving in Tokyo. Victors will accept gold medals passed to them on trays. Even the specter of cheating has evolved. As technologies like CRISPR leap ahead, a newer threat looms, unsteadily: gene doping.
The World Anti-Doping Agency (WADA) recently barred U.S. track star Shelby Houlihan from the Olympic trials after she tested positive for steroids—which Houlihan blamed on a pig organ meat burrito. The agency also banned sprinter and gold medal favorite Sha’Carri Richardson after she tested positive for THC. In addition to those traditional banned substances, WADA has long banned genetically modified cells and alterations of genome sequences or gene expression “by any...
Related Articles
By Samuelle Fajutrao Falk , The Conversation | 06.26.2026
When my colleagues and I asked autistic people and parents of autistic children in Sweden how they feel about genetic research in autism, one response stood out: “I hope genetic research finds new ways to help us, not erase us.”...
By Rebecca Simkin, BioNews | 06.29.2026
The US Food and Drug Administration (FDA) is allowing biotech company Regenxbio to reapply for licensing of a gene therapy for Hunter syndrome, in a reversal of its previous decision. Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Paul Knoepfler, Stat | 06.24.2026
What if you could precisely change the genome of a pre-implantation human embryo and then safely use that embryo to try to generate a healthier person? It’s a wild idea, but one that technology over the past decade has steadily...